UBS analyst Damian Karas initiates coverage on Xylem (NYSE:XYL) with a Buy rating and announces Price Target of $165.
UBS Initiates Coverage On Xylem With Buy Rating, Announces Price Target of $165
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.